These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 8641182)

  • 1. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption.
    Vitté C; Fleisch H; Guenther HL
    Endocrinology; 1996 Jun; 137(6):2324-33. PubMed ID: 8641182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.
    Sahni M; Guenther HL; Fleisch H; Collin P; Martin TJ
    J Clin Invest; 1993 May; 91(5):2004-11. PubMed ID: 8486770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term culture of disaggregated rat osteoclasts: inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrP[107-139].
    Fenton AJ; Martin TJ; Nicholson GC
    J Cell Physiol; 1993 Apr; 155(1):1-7. PubMed ID: 8468357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between effects of parathyroid hormone and bisphosphonate on regulation of osteoclast activity by the osteoblast-like cell line UMR-106.
    Yu X; Schøller J; Foged NT
    Bone; 1996 Oct; 19(4):339-45. PubMed ID: 8894139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures.
    Kawaguchi H; Chikazu D; Nakamura K; Kumegawa M; Hakeda Y
    J Bone Miner Res; 2000 Mar; 15(3):466-73. PubMed ID: 10750561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures.
    Nishikawa M; Akatsu T; Katayama Y; Yasutomo Y; Kado S; Kugal N; Yamamoto M; Nagata N
    Bone; 1996 Jan; 18(1):9-14. PubMed ID: 8717530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors.
    Van Beek ER; Löwik CW; Papapoulos SE
    Bone; 2002 Jan; 30(1):64-70. PubMed ID: 11792566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate.
    Schmidt A; Rutledge SJ; Endo N; Opas EE; Tanaka H; Wesolowski G; Leu CT; Huang Z; Ramachandaran C; Rodan SB; Rodan GA
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3068-73. PubMed ID: 8610169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of two novel bisphosphonates on bone cells in vitro.
    Evans CE; Braidman IP
    Bone Miner; 1994 Aug; 26(2):95-107. PubMed ID: 7994190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement by conditioned medium of stretched calvarial bone cells of the osteoclast-like cell formation induced by parathyroid hormone in mouse bone marrow cultures.
    Soma S; Matsumoto S; Takano-Yamamoto T
    Arch Oral Biol; 1997 Mar; 42(3):205-11. PubMed ID: 9188990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive expression of osteoclast-stimulating activity by normal clonal osteoblast-like cells: effects of parathyroid hormone and 1,25-dihydroxyvitamin D3.
    Collin P; Guenther HL; Fleisch H
    Endocrinology; 1992 Sep; 131(3):1181-7. PubMed ID: 1505460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cellular actions of interleukin-11 on bone resorption in vitro.
    Hill PA; Tumber A; Papaioannou S; Meikle MC
    Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The biological function of platelet-derived growth factor-BB in the osteoblast-osteoclast co-culture system].
    Zhang Z; Chen J; Jin D
    Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):425-8. PubMed ID: 11798912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells.
    Wei P; Jiao L; Qin LP; Yan F; Han T; Zhang QY
    Zhong Xi Yi Jie He Xue Bao; 2009 Apr; 7(4):342-8. PubMed ID: 19361364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy.
    Sato M; Grasser W
    J Bone Miner Res; 1990 Jan; 5(1):31-40. PubMed ID: 2106763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts.
    Perez-Amodio S; Beertsen W; Everts V
    J Bone Miner Res; 2004 Oct; 19(10):1722-31. PubMed ID: 15355568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro.
    Qu Q; Härkönen PL; Mönkkönen J; Väänänen HK
    Bone; 1999 Aug; 25(2):211-5. PubMed ID: 10456387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
    Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
    Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.
    Coxon FP; Helfrich MH; Van't Hof R; Sebti S; Ralston SH; Hamilton A; Rogers MJ
    J Bone Miner Res; 2000 Aug; 15(8):1467-76. PubMed ID: 10934645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.